← Leaderboards
Blaine A. Pfeifer
Tufts University Medford
$3,688,145
Attributed
$5,194,091
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $902.4K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,194,091 · 7
By mechanism
R01$3,035,203 · 2
R21$1,315,877 · 3
R43$698,423 · 1
R03$144,588 · 1
Top collaborators
- Jason B Muhitch3 shared
- Elsa Bou Ghanem2 shared
- David H Sherman2 shared
- David Alan Mead1 shared
- Scott Allen Monsma1 shared
Most similar at Tufts University Medford
Same institution · by research overlap
- Joshua A Kritzer$8,375,849
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignEngineeringTechnologyVaccinesAntigensSuccessImmune ResponseVaccinationSurfaceImmunizationFutureProteinsImmuneNovel VaccinesBiologicalPneumococcal InfectionsEconomicsInnovationGeneticSerotypingStreptococcus PneumoniaeBiomedical EngineeringMethodologyBiocompatible Materials
Grant awards (17)
Targeted Gene Delivery and Human Dendritic Cell Maturation Through a Novel Hybrid Biological-Biomaterial Vector System$478,685
R01 · FY2025 · CA · contact PI
Liposomal Encapsulation Vaccine Design for Pneumococcal Disease in Aged Subjects$396,319
R01 · FY2025 · AG · contact PI
Targeted Gene Delivery and Human Dendritic Cell Maturation Through a Novel Hybrid Biological-Biomaterial Vector System$454,261
R01 · FY2024 · CA · contact PI
Liposomal Encapsulation Vaccine Design for Pneumococcal Disease in Aged Subjects$404,206
R01 · FY2024 · AG · contact PI
Targeted Gene Delivery and Human Dendritic Cell Maturation Through a Novel Hybrid Biological-Biomaterial Vector System$499,389
R01 · FY2023 · CA · contact PI
Liposomal Encapsulation Vaccine Design for Pneumococcal Disease in Aged Subjects$402,990
R01 · FY2023 · AG · contact PI
Liposomal Encapsulation Vaccine Design for Pneumococcal Disease in Aged Subjects$399,353
R01 · FY2022 · AG · contact PI
The efficacy of Liposomal Encapsulation of Polysaccharides pneumococcal vaccine in protecting aged hosts against invasive Streptococcus pneumoniae infections in murine models$198,206
R21 · FY2020 · AG
The efficacy of Liposomal Encapsulation of Polysaccharides pneumococcal vaccine in protecting aged hosts against invasive Streptococcus pneumoniae infections in murine models$238,104
R21 · FY2019 · AG
An in vitro Microscale Platform for Antibiotic Biosynthesis and Discovery$195,519
R21 · FY2018 · AI · contact PI
An in vitro Microscale Platform for Antibiotic Biosynthesis and Discovery$249,305
R21 · FY2017 · AI · contact PI
A Hybrid Bio-synthetic Vector Designed to Elicit Directed in vivo Immune Response$195,929
R21 · FY2017 · AI · contact PI
Expression Enhanced Natural Product Pathways Using Advanced Metagenomic Tools$348,423
R43 · FY2016 · AT
A Hybrid Bio-synthetic Vector Designed to Elicit Directed in vivo Immune Response$238,814
R21 · FY2016 · AI · contact PI
Expression Enhanced Natural Product Pathways Using Advanced Metagenomic Tools$350,000
R43 · FY2015 · AT
A Hybrid Biomaterial-biological Vector for Antigen Presenting Cell Gene Delivery$72,206
R03 · FY2011 · AI · contact PI
A Hybrid Biomaterial-biological Vector for Antigen Presenting Cell Gene Delivery$72,382
R03 · FY2010 · AI · contact PI